ResearcherCentral South UniversityNo recent work listed

Yongjun Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1889-3914; OpenAlex author ID A5083035457. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper

Papers 2

miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway. Co-author DOI 10.1007/s13277-012-0446-8 ↗
Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in pancreatic cancer. Co-author DOI 10.1007/s12032-010-9480-9 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Weijia Sun · 2 shared papers, 2011–2012 · strength 0.07
- Paper miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway. DOI 10.1007/s13277-012-0446-8 ↗
- Paper Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in p… DOI 10.1007/s12032-010-9480-9 ↗
Kemin Wu · 1 shared paper, 2012 · strength 0.04
- Paper miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway. DOI 10.1007/s13277-012-0446-8 ↗
Yuxiang Chen · 1 shared paper, 2012 · strength 0.04
- Paper miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway. DOI 10.1007/s13277-012-0446-8 ↗
Yebin Lu · 1 shared paper, 2011 · strength 0.03
- Paper Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in p… DOI 10.1007/s12032-010-9480-9 ↗
Xiaohui Duan · 1 shared paper, 2011 · strength 0.03
- Paper Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in p… DOI 10.1007/s12032-010-9480-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.